Akzo Nobel N.v. · EURONEXT:AKZA
Akzo Nobel — Shareholder Meeting (November 2017)
20 slides from Akzo Nobel's shareholder meeting presentation, Nov 30, 2017
Slide 1: Extraordinary General Meeting
Extraordinary General Meeting November 30, 2017
Slide 2: Agenda
Agenda 1. Appointment of Mr. M.J. de Vries as member of the Board of Management with effect from January 1, 2018 (voting point) 2. Appointments to the Supervisory Board a) Appointment of Mr. P.W. Thomas as member of the Supervisory Board with effect from November 30, 2017 (voting point) b) Appointme
Slide 3: Agenda item 1: Appointment Mr De Vries
Agenda item 1: Appointment Mr De Vries
Slide 4: Appointment of Mr Maarten de Vries
Appointment of Mr Maarten de Vries • Former CFO and Executive Board member at Intertrust Group and TNT Express • Former CEO of TP Vision • Various senior positions at Royal Philips Electronics, including Chief Information Officer and Chief Purchasing Officer EGM November 30, 2017 4
Slide 5: Switch to voting slide
Switch to voting slide EGM November 30, 2017 5
Slide 6: Agenda item 2: Appointments to the Supervisory Board
Agenda item 2: Appointments to the Supervisory Board
Slide 7: Nominees for the Supervisory Board
Nominees for the Supervisory Board Ms. Sue Clark Mr. Patrick Thomas Mr. Michiel Jaski • Non-Executive director Britvic plc, • Chairman and CEO Covestro A.G. • Former CEO of OFFICEFIRST Bakkavor Group plc, and Tulchan • Former Chairman and CEO Bayer Immobilien and Grontmij Communications LLP Material
Slide 8: Switch to voting slide
Switch to voting slide EGM November 30, 2017 8
Slide 9: Agenda item 3: Separation of Specialty Chemicals
Agenda item 3: Separation of Specialty Chemicals
Slide 10: Creation of two focused businesses to unlock further value and accelerate growth
Creation of two focused businesses to unlock further value and accelerate growth 2017 onwards: Unlocking further value and accelerating growth 2016: Continuous Two focused improvement businesses and growth High-performing 2013-2015: Building the Scale and foundation capabilities to stand on their ow
Slide 11: World class Specialty Chemicals business
World class Specialty Chemicals business €4.8bn revenue €953m EBITDA North America Mature Europe Emerging Europe Asia Pacific 24% 43% 4% 17% €629m EBIT 13.2% ROS 17.9% ROI 9,000 people Balanced portfolio of interlinked businesses High profitability in all businesses Proven resilience of portfolio th
Slide 12: Separation on track to take place by April 2018
Separation on track to take place by April 2018 Nov 30, 2017 Dec 7, 2017 Jan 1, 2018 Apr, 2018 Q2/ Q3, 2018 EGM to approve Advance proceeds of Internal External separation of Distribution of vast majority of separation of separation paid as separation of Specialty Chemicals net proceeds from separat
Slide 13: Approval for separation through dual-track process
Approval for separation through dual-track process Internal separation External separation Dual-track process Private sale Scope of requested shareholder approval Paints Coatings Specialty Chemicals Demerger IPO Transaction scope EGM November 30, 2017 13
Slide 14: Private sale process (private track)
Private sale process (private track) 1 Controlled auction to ensure competitive process 2 Multiple interested parties, both strategic and private equity Information Possibility for due Submission of memorandum Submission of non- diligence and binding offers provided to binding offers engagement with
Slide 15: Demerger process (public track)
Demerger process (public track) Prior to demerger Following demerger Highlights Separate listed entity for 1:1 Specialty Chemicals business Public Public Public shareholders shareholders shareholders Akzo Nobel N.V. shareholders will receive shares in Specialty Chemicals entity Akzo Nobel Akzo Nobel
Slide 16: Dual-track decision criteria and proceeds
Dual-track decision criteria and proceeds Decision criteria Separate Vast majority of listed Demerger Financial net proceeds entity Value returned to Specialty Chemicals Tax shareholders Liabilities/ pensions Other €1bn advance Speed/ timeline proceeds as Risk/ certainty special dividend, Sale Priva
Slide 17: Questions on: Separation of Specialty Chemicals
Questions on: Separation of Specialty Chemicals
Slide 18: Switch to voting slide
Switch to voting slide EGM November 30, 2017 18
Slide 19: Update on recent developments
Update on recent developments Thierry Vanlancker – CEO
Slide 20: Thank you
Thank you